摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Boc-Pro-ONp | 28310-65-8

中文名称
——
中文别名
——
英文名称
Boc-Pro-ONp
英文别名
1-O-tert-butyl 2-O-(4-nitrophenyl) (2S)-pyrrolidine-1,2-dicarboxylate
Boc-Pro-ONp化学式
CAS
28310-65-8
化学式
C16H20N2O6
mdl
MFCD00037323
分子量
336.345
InChiKey
GUVOBXQVANZIKH-ZDUSSCGKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    463.6±40.0 °C(Predicted)
  • 密度:
    1.284±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    24
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    102
  • 氢给体数:
    0
  • 氢受体数:
    6

安全信息

  • 海关编码:
    2933990090

SDS

SDS:7586d14c45371e71e3cdca88ad2ec335
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    Boc-Pro-ONp 在 potassium fluoride 、 氯化镍二甲氧基乙烷18-冠醚-6N,N-二异丙基乙胺三氟乙酸sodium t-butanolate 作用下, 以 四氢呋喃二氯甲烷N,N-二甲基乙酰胺乙腈 为溶剂, 反应 65.0h, 生成 (2R,3S)-1-(L-prolyl)-2-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indoline
    参考文献:
    名称:
    镍催化吲哚的脱芳香芳基硼化:区域选择性合成 C2- 和 C3- 硼化吲哚啉
    摘要:
    吲哚脱芳构化是获取二氢吲哚的重要策略:二氢吲哚是存在于多种天然产物和生物活性分子中的基序。本文提出了一种过渡金属催化吲哚区域选择性脱芳香芳基硼化反应生成多种二氢吲哚的方法。该方法通过在 C2-或 C3-位置上缺乏激活或导向基团的底物上的迁移插入途径实现简单吲哚的分子间脱芳构化。合成有用的 C2- 和 C3- 硼酸化二氢吲哚可以通过简单改变N-保护基团以高区域选择性和非对映选择性(高达 >40:1 rr 和 >40:1 dr)从容易获得的起始材料获得。此外,通过实验和计算探索了区域选择性的起源,以揭示吲哚上N保护基团的羰基取向、C2-C3 π 键的电子和空间之间的显着相互作用。该方法首次实现了 (−)-azamedicarpin 的对映选择性合成。
    DOI:
    10.1021/jacs.1c05902
  • 作为产物:
    描述:
    L-脯氨酸盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺三乙胺 作用下, 以 二氯甲烷 为溶剂, 反应 15.0h, 生成 Boc-Pro-ONp
    参考文献:
    名称:
    Design, synthesis, and biological evaluation of novel stachydrine derivatives as potent neuroprotective agents for cerebral ischemic stroke
    摘要:
    Stachydrine is a natural product with multiple protective biological activities, including those involved in preventing cancer, ischemia, and cardiovascular disease. However, its use has been limited by low bioavailability and unsatisfactory efficacy. To address this problem, a series of stachydrine derivatives (A1/A2/A3/A4/B1/B2/B3/B4) were designed and synthesized, and biological studies were carried out in vitro and in vivo. When compared with stachydrine, Compound B1 exhibited better neuroprotective effects in vitro, and significantly reduced infarction size in the model of the middle cerebral artery occlusion rat model. Therefore, Compound B1 was selected for further research on ischemic stroke.
    DOI:
    10.1007/s00210-020-01868-4
点击查看最新优质反应信息

文献信息

  • Oxaziridine-Mediated Oxyamination of Indoles: An Approach to 3-Aminoindoles and Enantiomerically Enriched 3-Aminopyrroloindolines
    作者:Tamas Benkovics、Ilia A. Guzei、Tehshik P. Yoon
    DOI:10.1002/anie.201004635
    日期:2010.11.22
    A radical solution: A highly regioselective copper(II)‐catalyzed oxyamination of N‐acyl indoles with oxaziridines gave aminal products that could be converted in a single step into 3‐aminoindoles and 3‐aminopyrroloindolines (see scheme). When a chiral N‐acyl group was used, the core fragment of some architecturally fascinating pyrroloindoline alkaloids was formed with 91 % ee. Bs=benzenesulfonyl, Moc=methoxycarbonyl
    自由基解决方案:高度区域选择性的铜(II)催化的N-酰基吲哚与氧氮丙啶的氧胺化产生的氨基产物可以在一步中转化为 3-氨基吲哚和 3-氨基吡咯并二氢吲哚(参见方案)。当使用手性N-酰基基团时,一些结构上引人入胜的吡咯并二氢吲哚生物碱的核心片段形成了 91% 的 ee。Bs=苯磺酰基,Moc=甲氧基羰基。
  • Proline-DerivedN-Sulfonylcarboxamides: Readily Available, Highly Enantioselective and Versatile Catalysts for Direct Aldol Reactions
    作者:Albrecht Berkessel、Burkhard Koch、Johann Lex
    DOI:10.1002/adsc.200404126
    日期:2004.8
    low catalyst loadings (5–10 mol %) and at room temperature, with ees ranging up to 98%, whereas L-proline itself afforded a maximum ee of 80% (in DMSO). Thus, N-arylsulfonyl derivatives of proline amide represent a novel class of highly enantioselective catalysts for direct aldol reactions. Furthermore, the N-arylsulfonyl substituent suggests possibilities for incorporation into larger catalyst assemblies
    不对称直接羟醛反应的脯氨酸催化涉及仲胺功能和氨基酸的羧基。已知N-磺酰基羧酰胺具有与羧酸相似的酸度,并且合成了L-脯氨酸酰胺的三种N-芳基磺酰基衍生物作为L-Pro的官能化和通用衍生物。通过将丙酮直接醇醛加成到4-硝基苯甲醛中来评估它们的催化性能。在低催化剂负载量(5-10 mol%)和室温下,各种溶剂均实现了显着改善的反应性和对映选择性,ee高达98%,而L-脯氨酸本身提供的ee最大为80%(在DMSO中) 。因此,N脯氨酸酰胺的-芳基磺酰基衍生物代表用于直接羟醛反应的一类新的高对映选择性催化剂。此外,N-芳基磺酰基取代基暗示了在不影响催化活性官能团的情况下掺入更大的催化剂组件(包括固定化)的可能性。
  • Amino acids and peptides. XXIX. Synthesis of peptide fragments related to active center of eglin c and studies on the relationship between their structure and their inhibitory activity against cathepsin G and .ALPHA.-chymotrypsin.
    作者:Kazunori NAKABAYASHI、Satoshi TSUBOI、Taizo FUJIMOTO、Yoshio OKADA、Yoko NAGAMATSU、Junichiro YAMAMOTO
    DOI:10.1248/cpb.38.3249
    日期:——
    H-Ser-Pro-Val-Thr-Leu-Asp-Leu-Arg-Tyr-OMe, corresponding to the sequence 41-49 of eglin c, inhibited human leukocyte cathepsin G and α-chymotrypsin. In order to gain further insight into the relationship between the structure and the inhibitory activity against cathepsin G and α-chymotrypsin, peptide fragments related to the above nonapeptide were synthesized by a conventional solution method and their inhibitory activities were examined. The smallest peptide which exhibited inhibitory effects on the above envymes was H-Pro-Val-Thr-Leu-OMe, corresponding to the sequence 42-45 of eglin c.
    H-Ser-Pro-Val-Thr-Leu-Asp-Leu-Arg-Tyr-OMe,对应于eglin c的第41-49位序列,对人类白细胞组织蛋白酶G和α-胰凝乳蛋白酶具有抑制作用。为了更深入地了解其结构与对组织蛋白酶G和α-胰凝乳蛋白酶抑制活性之间的关系,通过常规液相方法合成了与上述九肽相关的片段,并检测了它们的抑制活性。对上述酶表现出抑制作用的最小肽是H-Pro-Val-Thr-Leu-OMe,对应于eglin c的第42-45位序列。
  • Amino acids and peptides. XXI. Synthesis of N-terminal heptapeptide of mammalian metallothionein(MT) and evaluation of its immunoreactivity.
    作者:YOSHIO OKADA、SHIN IGUCHI、SHIGERU NAKAYAMA、YUTAKA KIKUCHI、MASACHIKA IRIE、JUN-ICHI SAWADA、HIDEHARU IKEBUCHI、TADAO TERAO
    DOI:10.1248/cpb.36.3614
    日期:——
    The common N-terminal heptapeptide, Ac-Met-Asp-Pro-Asn-Cys-Ser-Cys-OH, Ac-(MT II 1-7)-OH, of mammalian metallothioneins (MTs) was synthesised by a conventional solution method using newly developed β-2-adamantylasparate. This peptide was as reactive as native MT with a monoclonal antibody produced against rat Zn-MT II.
    哺乳动物金属硫蛋白(MTs)的共同N端七肽Ac-Met-Asp-Pro-Asn-Cys-Ser-Cys-OH,即Ac-(MT II 1-7)-OH,通过使用新开发的β-2-金刚烷基天冬氨酸,采用传统的溶液方法合成。该肽与针对大鼠Zn-MT II产生的单克隆抗体同样具有反应性。
  • Amino Acids and Peptides. XXXVII. Synthesis of Stereoisomeric Nonapeptides Corresponding to Sequence 41-49 of Eglin c and Examination of Their Inhibitory Activity against Human Leukocyte Cathepsin G and .ALPHA.-Chymotrypsin.
    作者:Ayumi FUJII、Satoshi TSUBOI、Keiichi ASADA、Yoko NAGAMATSU、Junichiro YAMAMOTO、Yoshio OKADA
    DOI:10.1248/cpb.42.1518
    日期:——
    A nonapeptide, H-Ser-Pro-Val-Thr-Leu-Asp-Leu-Arg-Tyr-OH, corresponding to sequence 41-49 of eglin c inhibited leukocyte cathepsin G and α-chymotrypsin with Ki values of 2.2×10-5 and 7.2×10-6M, respectively, although eglin c itself inhibited leukocyte elastase, cathepsin G and α-chymotrypsin with Ki values of 6.0×10-9, 5.5×10-9 and 2.5×10-9M, respectively. The inhibitory activity of the nonapeptide decreased following incubation with cathepsin G due to the cleavage of the Leu45-Asp46 peptide bond. Therefore, Leu45 and/or Asp46 were replaced with D-amino acids and the inhibitory activities of the resultant nonapeptides were examined. Their inhibitory activities against cathepsin G and α-chymotrypsin were much weaker than those of the all-L-type nonapeptide, suggesting that the amino acids at the active site, Leu45 and Asp46 are required to be in the L-configuration for potent activity.
    一种非apeptide,H-Ser-Pro-Val-Thr-Leu-Asp-Leu-Arg-Tyr-OH,对应于eglin c序列41-49,分别以2.2×10-5和7.2×10-6M的Ki值抑制白细胞组织蛋白酶G和α-胰凝乳蛋白酶,尽管eglin c本身分别以6.0×10-9、5.5×10-9和2.5×10-9M的Ki值抑制白细胞弹性蛋白酶、组织蛋白酶G和α-胰凝乳蛋白酶。非apeptide的抑制活性在与组织蛋白酶G孵育后下降,这是由于Leu45-Asp46肽键的断裂。因此,Leu45和/或Asp46被替换为D-氨基酸,并对产生的非apeptide的抑制活性进行了检查。它们对组织蛋白酶G和α-胰凝乳蛋白酶的抑制活性远弱于所有L型非apeptide,表明活性位点上的氨基酸,Leu45和Asp46,需要处于L-构型才能发挥强大活性。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物